Richardson Financial Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-819
Closed -$21.9K 618
2025
Q4
$21.9K Buy
819
+208
+34% +$5.36K 0.01% 395
2025
Q3
$16.3K Buy
+611
New +$15.8K 0.01% 399
2025
Q1
Sell
-246
Closed -$9.06K 604
2024
Q4
$9.06K Buy
246
+3
+1% +$137 0.01% 408
2024
Q3
$9.72K Hold
243
0.01% 400
2024
Q2
$9.72K Buy
243
+136
+127% +$5.64K 0.01% 384
2024
Q1
$4.7K Sell
107
-64
-37% -$3.31K ﹤0.01% 470
2023
Q4
$10.6K Buy
+171
New +$8.98K 0.01% 305

Other funds holding AMPH

Richardson Financial Services's AMPH Position: Q1 2026 in Review

Richardson Financial Services sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 819 shares — an estimated $21.9K sold.

Richardson Financial Services first reported a position in AMPH in Q4 2023 and held it in 7 quarters. The position peaked at $21.9K in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Richardson Financial Services reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Richardson Financial Services sold 819 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $21.9K.
  • Richardson Financial Services first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 7 quarters.
  • Richardson Financial Services's Amphastar Pharmaceuticals position peaked at $21.9K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Richardson Financial Services's 13F filing for Q1 2026, filed 4 May 2026.